Stocks and Investing Stocks and Investing
Mon, November 21, 2022

Ami Fadia Maintained (AVDL) at Strong Buy with Increased Target to $9 on, Nov 21st, 2022


Published on 2024-10-28 00:16:34 - WOPRAI, Ami Fadia
  Print publication without navigation


Ami Fadia of Needham, Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Increased Target from $8 to $9 on, Nov 21st, 2022.

Ami has made no other calls on AVDL in the last 4 months.



There are 2 other peers that have a rating on AVDL. Out of the 2 peers that are also analyzing AVDL, 1 agrees with Ami's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Increased Target to $8 on, Wednesday, August 10th, 2022


This is the rating of the analyst that currently disagrees with Ami


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $12 on, Thursday, August 11th, 2022
Contributing Sources